Warren Buffett's Berkshire Hathaway reveals stakes in AbbVie, Merck, Pfizer, and other 'big pharma' stocksBusiness Insider • 11/16/20
Bristol Myers Squibb Provides Regulatory Update on Lisocabtagene Maraleucel (liso-cel)Business Wire • 11/16/20
Bristol Myers Squibb to Participate in Wolfe Research's 2nd Annual Virtual Healthcare ConferenceBusiness Wire • 11/11/20
Bristol Myers Squibb Presents Late-Breaking Phase 2 Data Demonstrating the Safety and Efficacy of Deucravacitinib (BMS-986165) in Patients with Psoriatic ArthritisBusiness Wire • 11/09/20
Bristol-Myers Squibb Contingent Value Rights: Inclined To Believe There's Still ValueSeeking Alpha • 11/06/20
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for First-Line Treatment of Metastatic Non-Small Cell Lung CancerBusiness Wire • 11/06/20
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/05/20
This Leading Pharma Stock Jumped On Its Third-Quarter Beat And RaiseInvestors Business Daily • 11/05/20
Bristol Myers Squibb's stock gains with Eliquis sales jumping 9% during the third quarterMarket Watch • 11/05/20
Bristol Myers Squibb Data at ACR Convergence 2020 Underscore Commitment to Advancing Science for Patients with Difficult-to-Treat Immune-Mediated DiseasesBusiness Wire • 11/05/20